🇺🇸 FDA
Patent

US 7214519

Screening method for identifying heme independent modulators of soluble guanylyl cyclase (sGC) activity using αβCys105 mutant sGC

granted A61KA61K38/00

Quick answer

US patent 7214519 (Screening method for identifying heme independent modulators of soluble guanylyl cyclase (sGC) activity using αβCys105 mutant sGC) held by The Board of Regents of the University of Texas System expires Mon May 03 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue May 08 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 03 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K38/00